PubRank

M M Zutter

Author PubWeight™ 30.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci 1995 2.39
2 Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell 1996 1.94
3 Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem 1991 1.79
4 Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. Leukemia 2000 1.60
5 Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test? Cancer 1998 1.49
6 Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer 1991 1.36
7 alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J Biol Chem 2000 1.22
8 The alpha 2 beta 1 integrin: a collagen receptor on platelets and other cells. Thromb Haemost 1995 1.14
9 Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells. Exp Cell Res 1992 1.14
10 A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol 1998 1.09
11 NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem 1997 1.09
12 Analysis of collagen receptors. Methods Enzymol 1994 1.09
13 Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol 2001 1.02
14 Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. J Biol Chem 2001 0.99
15 Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: the role of the alpha6 and beta4 integrin subunits. Cancer Res 1998 0.94
16 Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin. J Clin Invest 1992 0.92
17 Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol 2001 0.91
18 PDGF induction of alpha 2 integrin gene expression is mediated by protein kinase C-zeta. J Cell Biol 1996 0.91
19 Juvenile chronic myelogenous leukemia. Am J Clin Pathol 1996 0.91
20 Collagen receptor integrins: rising to the challenge. Curr Drug Targets 2008 0.90
21 Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas. Am J Clin Pathol 2000 0.89
22 Megakaryoblastic leukemia presenting as a temporal bone granulocytic sarcoma. Case report. J Neurosurg 1993 0.85
23 Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry. Am J Clin Pathol 1996 0.85
24 Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods. Am J Clin Pathol 1999 0.81
25 Recurrent neuroendocrine (Merkel cell) carcinoma of the skin presenting as marrow failure in a man with systemic lupus erythematosus. Med Pediatr Oncol 1993 0.79
26 Role of the alpha1 and alpha2 integrin cytoplasmic domains in cell morphology, motility and responsiveness to stimulation by the protein kinase C pathway. Cell Adhes Commun 2000 0.77
27 Gastrointestinal carcinoma antigen GA733: target for immunodestruction and potential modifier of invasiveness and chemoresponsiveness. J Natl Cancer Inst 1998 0.75
28 Necrotizing granulomatosis of the spleen in chronic granulomatous disease. Am J Dis Child 1990 0.75
29 Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia. Arch Pathol Lab Med 2000 0.75
30 Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia. Br J Haematol 1994 0.75